Veterinary Antimicrobial Susceptibility Testing Market to Reach USD 61.76 Billion by 2032, Driven by Rising Incidence of Animal Infectious Diseases

The Global Veterinary Antimicrobial Susceptibility Testing Market size was USD 39.47 Billion in 2022 and is projected to reach USD 61.76 Billion by 2032, with a compound annual growth rate (CAGR) of 5.10% during the forecast period. The market's growth is primarily driven by factors such as the increasing incidence of infectious diseases in animals and the growing demand for accurate and reliable veterinary antimicrobial susceptibility testing.

One of the key drivers of market revenue growth is the rising demand for livestock and companion animals. The growing need for meat and dairy products has led to increased livestock production, which in turn has raised the risk of infectious diseases in animals. Veterinary antimicrobial susceptibility testing plays a crucial role in ensuring the safety of animal products and preventing the spread of diseases.

Furthermore, the market is fueled by the increasing awareness of responsible antimicrobial use in veterinary care. The misuse and overuse of antimicrobial agents in animal health can lead to antimicrobial resistance, posing significant risks to both animal and human health. Strict regulations have been put in place to address this issue, driving the demand for veterinary antimicrobial susceptibility testing.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/download-free-sample/6423

The market is also benefiting from the rising adoption of companion animals and the growth of the pet insurance sector. As more households include companion animals, owners place a high value on their health and well-being. Veterinary antimicrobial susceptibility testing is crucial for accurate diagnosis and treatment of infectious diseases in companion animals.

Factors such as the prevalence of antibiotic resistance, the demand for animal-derived food products, and the awareness among pet owners regarding the importance of accurate diagnosis and treatment of animal diseases are driving the revenue growth of the global veterinary antimicrobial susceptibility testing market. Furthermore, the development of advanced testing technologies, including automated susceptibility testing systems and point-of-care testing devices, is expected to create new opportunities for market growth.

The adoption of digital technologies such as telemedicine and cloud-based data management is also contributing to market growth. These technologies enable veterinarians to obtain test results in real-time and collaborate with other professionals. Remote monitoring and management of animal health through these technologies are expected to drive the demand for veterinary antimicrobial susceptibility testing solutions.

However, the high cost of veterinary antimicrobial susceptibility testing and the shortage of qualified veterinary professionals are expected to hinder market revenue growth. The lack of standardization in testing procedures and the availability of alternative diagnostic techniques are also likely to impede market growth.

Some of the major companies in the global Veterinary Antimicrobial Susceptibility Testing Market are:
• Thermo Fisher Scientific, Inc.
• BIOTECON Diagnostics GmbH
• Neogen Corporation
• Merck KGaA
• Danaher Corporation
• Becton, Dickinson and Company
• Zoetis Inc.
• Bio-Rad Laboratories, Inc.
• Creative Diagnostics
• Qiagen N.V.
• Accelerate Diagnostics, Inc.

Segments Covered in the Report -
This report provides a comprehensive analysis of the global veterinary antimicrobial susceptibility testing market, offering historical data and forecasting revenue growth at a global, regional, and country level from 2019 to 2032. The report examines market trends and segments the market based on product type, animal type, and region.

In terms of product type, the market is categorized into Type 1, Type 2, Type 3, and others. These segments represent different types of veterinary antimicrobial susceptibility testing methods and solutions. The report provides revenue projections for each product type over the forecast period.

The market is further segmented based on animal type into companion animals and livestock animals. Companion animals include pets such as dogs, cats, and birds, while livestock animals encompass farm animals like cattle, poultry, and swine. The analysis provides insights into the revenue growth and market trends for veterinary antimicrobial susceptibility testing in each animal type.

On a regional level, the report covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Within these regions, specific countries are highlighted for a more detailed analysis. For North America, the report focuses on the United States, Canada, and Mexico. In Europe, the market outlook includes Germany, the United Kingdom, France, Italy, Spain, Sweden, BENELUX, and the rest of Europe. The analysis also covers China, India, Japan, South Korea, and the rest of the Asia-Pacific region. In Latin America, Brazil and the rest of LATAM are considered, while the Middle East & Africa section includes Saudi Arabia, the United Arab Emirates, South Africa, Israel, and the rest of MEA.

The report provides revenue estimates for each region and country, allowing for a comprehensive understanding of market trends and opportunities in different geographical areas. By analyzing the market at various levels, the report offers valuable insights into the growth potential and dynamics of the global veterinary antimicrobial susceptibility testing market.

Access Full Report Description with Research Methodology and Table of Contents @https://www.reportsanddata.com/report-detail/veterinary-antimicrobial-susceptibility-testing-market

Strategic Development:
• Zoetis Inc. introduced the VetMAX MastiSURE 24-hour, an antimicrobial susceptibility test, in 2021. This test aids in the prompt and accurate diagnosis of mastitis infections in dairy cows, enabling effective treatment decisions by veterinary professionals.

• Merck KGaA announced its acquisition of Themis Bioscience in 2020, a company specializing in vaccine research and development. This strategic move aimed to enhance Merck's presence in the animal health market, including the advancement of vaccines and antimicrobial treatments.

• Thermo Fisher Scientific, Inc. completed the acquisition of Brammer Bio in 2019, a viral vector manufacturing company, for USD 1.7 billion. This acquisition aimed to expand Thermo Fisher's capabilities in gene therapy and vaccine production, including the development of novel antimicrobial treatments for animals.

• Neogen Corporation launched the AccuPoint Advanced ATP hygiene monitoring system in 2019 for the animal health industry. This system utilizes ATP detection to monitor and improve hygiene practices in animal production facilities, thereby ensuring a healthier environment.

• Becton, Dickinson and Company finalized the acquisition of C.R. Bard in 2018, a medical technology company specializing in vascular and oncology products. This acquisition aimed to broaden Becton, Dickinson and Company's product portfolio in the animal health market.

• Danaher Corporation introduced the Sensititre Veterinary Antimicrobial Susceptibility Testing System in 2021, specifically designed for veterinary use. This testing system employs a standardized broth microdilution method, delivering reliable and accurate results for veterinary professionals.

• Qiagen N.V. launched the QIAstat-Dx Respiratory SARS-CoV-2 Panel in 2020, designed to detect SARS-CoV-2 in both humans and animals. This testing panel includes assays for identifying viral and bacterial pathogens causing respiratory infections in animals, providing comprehensive diagnostic capabilities.

• Neogen Corporation unveiled the AccuClean Advanced Listeria species test in 2019, a novel test for the detection and quantification of Listeria species in environmental samples. This test finds utility in animal production facilities to monitor and enhance hygiene practices effectively.

Request a customization of the report @
https://www.reportsanddata.com/request-customization-form/6423

Read More About:

Homocystinuria Market- https://www.reportsanddata.com/report-detail/homocystinuria-market

Siding Market- https://www.reportsanddata.com/report-detail/siding-market

3D Bioprinting Market - https://www.reportsanddata.com/report-detail/3d-bioprinting-market

Abdominal Aortic Aneurysm (AAA) Repair Devices Market - https://www.reportsanddata.com/report-detail/abdominal-aortic-aneurysm-repair-device-market

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: http://www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

This release was published on openPR.